Petauri LLC

Rapidly growing pharmaceutical services provider announces the formation of its internal collective of former access decision-makers NASHVILLE, Tenn., Jan. 9, 2025 /PRNewswire/ -- Petauri, a leading purpose-built pharmaceutical services provider, announced today the launch of its Access Customer Experience ("ACE") team, an internal collective of industry experts who provide unparalleled insights and strategies for market access. Recently featured in PM360's Innovation Issue, the ACE team is noted for bringing together an elite group of former access decision-makers hailing from influential US payers, health systems, and policy organizations. This team leverages their real-world experience to deliver actionable insights that bridge the gap between innovative therapies and the complex healthcare ecosystem they aim to impact. The team's unique value lies in its ability to offer firsthand knowledge of how decisions are made at every level of the access journey. From pricing and reimbursement strategies to stakeholder engagement and policy navigation, the ACE team delivers practical guidance tailored to meet the demands of diverse stakeholder needs. In addition, the ACE team is instrumental in training and equipping clients' customer-facing teams to successfully engage market access decision-makers in critical business-to-business discussions. "Having these experts integrated into every client engagement gives Petauri and our valued clients a distinct edge," said Dan Renick, CEO. "They know firsthand what it takes to secure access in a crowded, highly regulated environment, and their collective insights allow us to develop strategies that cut through the noise to ensure our clients' innovations are not only noticed but adopted." Renick added, "When considering the depth, breadth, and recency of experience, Petauri's ACE team is unrivaled in the industry and contributes greatly to our industry-leading growth." This team's expertise is integrated into every client engagement, ensuring all strategies benefit from the ACE team's real-world experiences and insights. By embedding this service as an extension of the organization's client partnership model, Petauri reaffirms its commitment to providing comprehensive support and driving successful market access outcomes for our clients. To learn more about Petauri's ACE team, including the industry professionals and respective experiences, please visit . About Petauri Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercialization support, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, and Formulary Insights, all now Powered by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit . Media Contact: Liz Gulino Petauri [email protected] 973-476-1751 SOURCE Petauri WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Rapidly growing pharmaceutical services provider unites existing capabilities into a comprehensive Medical Communications platform NASHVILLE, Tenn., Oct. 8, 2024 /PRNewswire/ -- Petauri, a leading purpose-built pharmaceutical services provider, announced today the formation of Petauri Advance, a forward-thinking medical communications platform. This platform is designed to integrate and optimize healthcare communications for the life sciences industry, bridging the gap between healthcare professionals, biopharmaceutical and diagnostic innovators, and patients. Petauri Advance offers a wide range of specialized services to support the diverse needs of the healthcare sector, including but not limited to: Continue Reading Petauri KOL engagement strategy and implementation Insight generation strategy and executing those insights into action Commercial development strategy, launch planning, and mapping Scientific communications and disease awareness Abstracts, publications, and trial education MSL training and engagement materials Conference and congress strategy, support and competitive intelligence Promotional and non-promotional content Digital strategy, implementation, and analytics The formation of Petauri Advance unites the highly acclaimed agencies acquired by Petauri throughout 2024, providing unrivaled therapeutic area breadth and depth combined with the agility, client service, and innovation of independent healthcare agencies. Petauri Advance is comprised of the following agencies, all Powered by Petauri™: Blendworks Bluprint Oncology Cogency DRIVE MOMENTUM PROPEL Verascity Science "We can now offer our clients scientific communications and therapeutic acumen across multiple therapeutic areas," stated Jan Hannon, Group President. "Our goal for Petauri Advance is to clarify complex science for those on the frontlines of care delivery to improve patient outcomes." "We are thrilled to introduce Petauri Advance as a powerful platform that will further enable us to deliver more impactful and efficient medical communications across a wide range of disease states," said Dan Renick, CEO of Petauri. "With the increasing demand for high-quality healthcare information and education, this unified group will provide a comprehensive solution that empowers healthcare professionals and proactively addresses the evolving needs of the industry." About Petauri Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercial services, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, and the agencies of the Brightly Network, all now Powered by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit Media Contact: Greg Pitkoff Glue Advertising and Public Relations [email protected] 718-404-9277 SOURCE Petauri WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

NEW YORK, May 16, 2024 /PRNewswire/ -- In honor of Mental Health Awareness Month, the Behavioral Health Leaders Network, a Kinetix Group network of excellence, announced it will rebrand as the Brain Health Leaders Network (BHLN). Launched in 2021, the network has served as a multistakeholder-led initiative focused on addressing and improving the management of unmet behavioral health needs. The rebrand acknowledges its increasing work to build consensus around different disease affinity categories including healthy aging, mental health, and neurology. Continue Reading Brain Health Leaders Network, a Kinetix Group network of excellence "Advancing the understanding of brain health and improving the detection, identification, and management of unmet behavioral and neurological health needs of our fellow citizens is one of the most important issues of our time," said Jerry Vaccaro, MD, co-chair of the BHLN. "Our organization is increasingly more focused on reducing stigma, enhancing access to appropriate care, and measuring and improving outcomes. Thought leadership through the Brain Health Leaders Network is key to guide these efforts, and I am honored to work with a group of clinicians, executives, and policymakers to advance these goals." The rebrand also broadens the scope to include more patient populations and the inequities experienced by those patients needing access to robust health care services. "It has been an honor to work with an organization that supports brain health efforts related to improving the management of unmet behavioral and neurological health needs with a focus on scalability and linkage to outcomes, quality of life, and health equity," said Mindy Olivarez, senior vice president at The Kinetix Group. For more information on the BHLN, visit here. To learn about ways to join the conversation in advancing brain health research, please contact Mindy Olivarez at [email protected]. The Kinetix Group (TKG) The Kinetix Group, a healthcare strategic advisory and marketing agency, is a part of Petauri. TKG empowers life science companies to effectively engage with health system and payer customers. With market access expertise, deep relationships, and connections that span the healthcare ecosystem, TKG is uniquely positioned to understand its clients' customers and design impactful solutions. Its core areas of focus are organized customers, market access, and real-world evidence. To learn more, visit . SOURCE The Kinetix Group